Factors predictive of postoperative morbidity and cost in patients with endometrial cancer

Obstetrics and Gynecology

Volumn 120, Issue 6, 2012, Pages 1419-1427

  Dowdy, Sean C ^a   Borah, Bijan J ^a   Bakkum Gamez, Jamie N ^a   Kumar, Sanjeev ^a   Weaver, Amy L ^a   McGree, Michaela E ^a   Haas, Lindsey R ^a   Cliby, William A ^a   Podratz, Karl C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGED; ARTICLE; CANCER INVASION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DEEP VEIN THROMBOSIS; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HYSTERECTOMY; LAPAROTOMY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MORBIDITY; OPERATION DURATION; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; CARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LAPAROTOMY; LYMPH NODE EXCISION; MIDDLE AGED; MORBIDITY; NEOPLASM INVASIVENESS; OPERATIVE TIME; POSTOPERATIVE COMPLICATIONS; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 84870216779     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3182737538     Document Type: Article

References (24)

1. Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: Randomized clinical trial. J Natl Cancer Inst 2008;100:1707-16.
2. Dowdy SC, Borah BJ, Bakkum-Gamez JN, Weaver AL, McGree ME, Haas LR, et al. Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in lowrisk endometrial cancer. Gynecol Oncol 2012;127:5-10.
3. Kitchener H, SwartAM,QianQ, Amos C, ParmarMK.Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): A randomised study. Lancet 2009;373:125-36.
4. Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC. Low-risk corpus cancer: Is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol 2000;182:1506-19. (Pubitemid 30437424)
5. Boll D, Verhoeven RH, van der Aa MA, Lybeert ML, Coebergh JW, Janssen-Heijnen ML. Adherence to national guidelines for treatment and outcome of endometrial cancer stage I in relation to co-morbidity in southern Netherlands 1995-2008. Eur J Cancer 2011;47:1504-10.
6. Truong PT, Kader HA, Lacy B, Lesperance M, MacNeil MV, Berthelet E, et al. The effects of age and comorbidity on treatment and outcomes in women with endometrial cancer. Am J Clin Oncol 2005;28:157-64.
7. Bakkum-Gamez JN, Mariani A, Dowdy SC, Weaver AL, McGree ME, Cliby WA, et al. The impact of surgical guidelines and periodic quality assessment on the staging of endometrial cancer. Gynecol Oncol 2011;123:58-64.
8. Strasberg SM, Linehan DC, Hawkins WG. The accordion severity grading system of surgical complications. Ann Surg 2009;250:177-86.
9. Hall BL, Hamilton BH, Richards K, Bilimoria KY, Cohen ME, Ko CY. Does surgical quality improve in the American College of Surgeons National Surgical Quality Improvement Program: An evaluation of all participating hospitals. Ann Surg 2009;250:363-76.
10. Khuri SF, Daley J, Henderson WG. The comparative assessment and improvement of quality of surgical care in the Department of Veterans Affairs. Arch Surg 2002;137:20-7. (Pubitemid 34041814)
11. Harrell F. Regression modeling strategies: With applications to linear models, logistic regression, and survival analysis. New York (NY): Springer; 2001.
12. Dunlay SM, Shah ND, Shi Q, Morlan B, VanHouten H, Long KH, et al. Lifetime costs of medical care after heart failure diagnosis. Circ Cardiovasc Qual Outcomes 2011;4:68-75.
13. Melton LJ III. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266-74.
14. Manning WG, Basu A, Mullahy J. Generalized modeling approaches to risk adjustment of skewed outcomes data. J Health Econ 2005;24:465-88. (Pubitemid 40461909)
15. Pregibon D. Goodness of link tests for generalized linear models. Appl Stat 1980;29:15-24.
16. Basu A, Manning WG, Mullahy J. Comparing alternative models: Log vs Cox proportional hazard? Health Econ 2004;13: 749-65. (Pubitemid 39136901)
17. Janda M, Gebski V, Brand A, Hogg R, Jobling TW, Land R, et al. Quality of life after total laparoscopic hysterectomy versus total abdominal hysterectomy for stage I endometrial cancer (LACE): A randomised trial. Lancet Oncol 2010;11: 772-80.
18. Wright JD, Lewin SN, Deutsch I, Burke WM, Sun X, Herzog TJ. Effect of surgical volume on morbidity and mortality of abdominal hysterectomy for endometrial cancer. Obstet Gynecol 2011;117:1051-9.
19. Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, et al. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study. J Clin Oncol 2012;30: 695-700.
20. Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J Clin Oncol 2009;27:5331-6.
21. Dowdy SC, Mariani A. Lymphadenectomy in endometrial cancer: When, not if. Lancet 2010;375:1138-40.
22. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): A retrospective cohort analysis. Lancet 2010;375:1165-72.
23. Dowdy SC, Aletti G, Cliby WA, Podratz KC, Mariani A. Extra-peritoneal laparoscopic para-aortic lymphadenectomy-a prospective cohort study of 293 patients with endometrial cancer. Gynecol Oncol 2008;111:418-24.
24. Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer. Am J Obstet Gynecol 2007;197:676 e1-7.